Platycodin D2
Based on 3 publication(s) in Google Scholar
Platycodin D2 is an orally active triterpenoid saponin found in Platycodon grandiflorum. Platycodin D2 induces mitophagy in cancer cells through NIX, thereby activating the P21/CyclinA2 pathway and promoting cell senescence. Platycodin D2 induces mitochondrial dysfunction, enhances autophagy, inhibits hepatocellular carcinoma cell proliferation, and exhibits anti-tumor activity against multiple cancer cell types. Platycodin D2 promotes mRNA expression of T-bet, GATA-3, Th1 cytokines IL-2 and IFN-γ, and Th2 cytokines IL-4 and IL-10, enhances splenocyte proliferation, and acts as a vaccine adjuvant with low rabbit red blood cell hemolytic activity. Platycodin D2 induces mitochondrial ROS production, incomplete autophagy, and ferroptosis to inhibit breast cancer cell proliferation. Platycodin D2 can be used for the research of cancer, inflammation and immunology.
연구목적의 판매만을 진행합니다. 환자를 대상으로 한 판매는 하지 않습니다.
- Purity : 99.84%
- CAS No.: 66663-90-9
- 화학식: C63H102O33
- 분자량:1387.46
-
보관:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
Publications Citing Use of MedChemExpress (MCE) Platycodin D2
More
Biological Activity
제품 설명
IC50 & Target
[2]|
IL-2 |
IL-4 |
IL-10 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HCT-15 | IC50 |
5.7 μM
Compound: 8, deapio-platycodin D
|
Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT15/CL02 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 20939516] |
| HCT-15 | IC50 |
9.6 μM
Compound: 8, deapio-platycodin D
|
Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human HCT15 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 20939516] |
| MES-SA | IC50 |
3.5 μM
Compound: 8, deapio-platycodin D
|
Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human MESSA cells after 48 hrs by sulforhodamine B assay
|
[PMID: 20939516] |
| MES-SA/Dx5 | IC50 |
5.2 μM
Compound: 8, deapio-platycodin D
|
Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay
Antiproliferative activity against human MESSA/DX5 cells after 48 hrs by sulforhodamine B assay
|
[PMID: 20939516] |
In Vitro
Platycodin D2 (1-100 μM; 48 h) specifically inhibits proliferation of Huh-7, MHCC97H, HCCLM3, HepG-2, SK-Hep1, and Huh-6 HCC cells with an IC50 of 10.2-12.7 μM, while having no significant cytotoxic effect on THLE-2 and L02 normal liver cells (IC50 >200 μM)[1].
Platycodin D2 (10 μM; 48 h) does not significantly induce apoptosis in Huh-7 or HCCLM3 HCC cells[1].
Platycodin D2 (10 μM; 24-48 h) induces robust autophagy in Huh-7 and HCCLM3 HCC cells, as evidenced by increased LC3 puncta formation, elevated autophagic flux, autophagolysosome formation, and altered expression of autophagy-related proteins, without affecting apoptosis-related proteins[1].
Platycodin D2 (5, 10 μM; 48 h) induces mitochondrial dysfunction in Huh-7 and HCCLM3 HCC cells, evidenced by increased ROS production, reduced mitochondrial membrane potential, and selective mitophagy via LC3 co-localization with damaged mitochondria[1].
Platycodin D2 (10 μM; 48 h) induces mitophagy in HCCLM3 HCC cells via NIX, as silencing NIX abrogates PD2's effects on autophagy, cell viability, mitochondrial function, and downstream P21/CyclinA2 expression[1].
Platycodin D2 (10 μM; 48 h) induces G2/M phase arrest and senescence in Huh-7 and HCCLM3 HCC cells, evidenced by altered cell cycle distribution, upregulated SASP gene expression, shifted expression of senescence-related proteins, increased β-galactosidase activity, reduced Lamin B1 levels, and nuclear γ-H2A.X aggregation[1].
Platycodin D2 (3.906-125 μg/mL; 30 min) exhibits haemolytic activity against 0.5% rabbit red blood cell suspensions with an HD50 of 18.57 μg/mL[2].
Platycodin D2 (0.0016-1.0 μg/mL; 16 h) significantly enhances mRNA expression of Th1 (IL-2, IFN-γ, T-bet) and Th2 (IL-4, IL-10, GATA-3) cytokines and transcription factors in Con A-stimulated naive ICR mouse splenocytes[2].
Platycodin D2 (5-50 μM; 48 h) potently inhibits the proliferation of MCF7, SKBR3, and Hs578T breast cancer cells with IC50 values of 14.62 μM, 29.60 μM, and 5.24 μM, respectively, after 48 h of incubation[3].
Platycodin D2 (5-50 μM; 48 h) blocks autophagy flux in MCF7, SKBR3, and Hs578T breast cancer cells by increasing LC3II/I and p62 expression while decreasing Syntaxin 17, SNAP29, VAMP8, and Lamp2b expression after 48 h of incubation[3].
Platycodin D2 (5-50 μM; 48 h) induces ferroptosis in MCF7, SKBR3, and Hs578T breast cancer cells by decreasing SLC7A11, GSH and GPX4 expression after 48 h of incubation[3].
Platycodin D2 (5-50 μM; 48 h) increases intracellular ferrous ion levels in MCF7, SKBR3, and Hs578T breast cancer cells after 48 h of incubation, a hallmark of ferroptosis[3].
Platycodin D2 (5-50 μM; 48 h) upregulates mitochondrial outer membrane protein TOM20 expression in MCF7, SKBR3, and Hs578T breast cancer cells after 48 h of incubation, indicating mitochondrial damage[3].
Platycodin D2 (5-50 μM; 48 h) increases intracellular MDA levels in MCF7, SKBR3, and Hs578T breast cancer cells after 48 h of incubation, indicating enhanced lipid peroxidation associated with ferroptosis[3].
Platycodin D2 (5-50 μM; 48 h) decreases intracellular SOD levels in MCF7, SKBR3, and Hs578T breast cancer cells after 48 h of incubation, reducing antioxidant capacity and promoting ferroptosis[3].
Platycodin D2 (5-50 μM; 48 h) increases mitochondrial ROS production and reduces mitochondrial membrane potential in MCF7, SKBR3, and Hs578T breast cancer cells after 48 h of incubation, contributing to mitochondrial damage[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Huh-7, MHCC97H, HCCLM3, HepG-2, SK-Hep1, Huh-6 hepatocellular carcinoma (HCC) cells, THLE-2, L02 normal liver cells
-
Concentration:1, 5, 10, 20, 50, 100 μM
-
Incubation Time:48 h
-
Result:Significantly reduced viability of all tested HCC cell lines, with IC50 values of 10.2 μM (Huh-7), 11.5 μM (MHCC97H), 10.4 μM (HCCLM3), 11.2 μM (HepG-2), 12.7 μM (SK-Hep1), and 11.8 μM (Huh-6).
Had no obvious inhibitory effect on normal THLE-2 and L02 liver cells, with IC50 values >200 μM for both.
-
Cell Line:Huh-7, HCCLM3 HCC cells
-
Concentration:10 μM
-
Incubation Time:24 h; 48 h
-
Result:Significantly increased the number of EGFP-LC3 puncta per cell (20 puncta for HCCLM3, 60 puncta for Huh-7, compared to near-zero in controls).
Showed significantly more red fluorescence than green fluorescence via mRFP-GFP-LC3 staining, indicating increased autophagic flux.
Revealed abundant autophagolysosomes in PD2-treated cells via transmission electron microscopy.
Increased LC3-II and Beclin 1 expression, and decreased P62 expression via Western blotting, while apoptosis-related proteins (Cleaved-caspase3, PARP, Cleaved-PARP) showed no significant changes.
-
Cell Line:Huh-7, HCCLM3 HCC cells
-
Concentration:10 μM
-
Incubation Time:48 h
-
Result:Induced G2/M phase arrest in HCC cells, with G2/M phase percentage increasing.
Showed significant upregulation of SASP genes (IL-6, IL-8, MMP3, TGF-β, IGFBP3, CXCL-1) in both cell lines via Real Time qPCR.
Revealed upregulated P21 and γ-H2A.X, and downregulated CDK1, CyclinA2, E2F, and p-RB via Western blotting.
Showed a significant increase in β-galactosidase positive cells, reduced Lamin B1 fluorescence and nuclear aggregation of γ-H2A.X in PD2-treated cells via β-galactosidase staining and immunofluorescence.
-
Cell Line:MCF7, SKBR3, Hs578T
-
Concentration:5, 10, 20 μM (MCF7, Hs578T); 25, 50 μM (SKBR3)
-
Incubation Time:48 h
-
Result:Upregulated the expression of LC3II/I and p62 proteins in all three breast cancer cell lines.
Downregulated the expression of Syntaxin 17, SNAP29, VAMP8, and Lamp2b proteins in all three breast cancer cell lines.\nDownregulated the expression of ferroptosis-related proteins SLC7A11 and GPX4 in all three breast cancer cell lines.\nSignificantly upregulated the expression of TOM20 in all three breast cancer cell lines.
In Vivo
Platycodin D2 (25-100 μg; s.c.; on Day 1 and Day 15) elicits balanced Th1 and Th2 immune responses in OVA (HY-W250978)-immunized ICR mice, significantly enhancing splenocyte proliferation, OVA-specific antibody titers at tested doses[2].
Platycodin D2 (2.5-5 mg/kg; i.g.; once every 2 days; 5 total doses) significantly inhibits breast cancer tumor growth in nude mice, with the 5 mg/kg dose reducing tumor volume by 80.5%, and mediates this effect via autophagy flux blockage and ferroptosis[3].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude mice (female, 5-6 weeks old, injected with 5×106 HCCLM3 cells in the right limb)[1]
-
Dosage:5 mg/kg; 10 mg/kg
-
Administration:intratumoral injection; once every 3 days; 4 doses
-
Result:Significantly inhibited tumor growth compared to the control group.
Reduced mean tumor volume to ~100 mm3 by week 4 at 5 mg/kg dose.
Reduced mean tumor volume to near 0 mm3 by week 4 at 10 mg/kg dose.
Maintained higher body weights than the control and 5-FU groups throughout the study.
Dose-dependently increased mean density of LC3-II, NIX, and P21 in tumor tissues.
Dose-dependently decreased mean density of Ki67 and Cyclin A2 in tumor tissues.
-
Animal Model:OVA-immunized ICR mice (female, 6 weeks old, 18-22 g)[2]
-
Dosage:25 μg; 50 μg; 75 μg; 100 μg
-
Administration:s.c.; on Day 1 and Day 15
-
Result:Significantly increased Con A- and LPS-stimulated splenocyte proliferation at 25 μg and 50 μg compared to the OVA control group (P<0.01 or P<0.001).
Significantly enhanced OVA-induced splenocyte proliferation at all four tested doses compared to the OVA control group (P<0.05 or P<0.01).
Significantly enhanced serum OVA-specific IgG, IgG1, IgG2a, and IgG2b antibody titers at all four tested doses compared to the OVA control group (P<0.01 or P<0.001).
Resulted in significantly higher IgG and IgG1 titers at 75 μg and 100 μg than the Alum-treated group (P<0.05).
-
Animal Model:BALB/c nude mice (female, 4-5 weeks old, subcutaneous MCF7 cell implantation tumor-bearing model)[3]
-
Dosage:2.5 mg/kg; 5 mg/kg
-
Administration:p.o.; once every 2 days; 5 total doses
-
Result:Reduced tumor volume by 80.5% at 5 mg/kg compared to control.
Reduced tumor volume by 65.8% at 2.5 mg/kg compared to control.
Did not affect mouse body weight.
Downregulated ferroptosis-related proteins SLC7A11 and GPX4 in tumor tissues.
Upregulated autophagy-related proteins LC3II and p62 in tumor tissues.
Increased ROS levels in tumor tissues.
Increased lipid peroxidation in tumor tissues.
Chemical Information
-
CAS No. 66663-90-9
-
Appearance Solid
-
분자량 1387.46
-
화학식 C63H102O33
-
Color Off-white to light yellow
-
SMILES
O[C@H]([C@@H]([C@@H](O[C@@]1([H])[C@@H]([C@H]([C@H](O)CO1)O[C@@]2([H])[C@@H]([C@](CO)(O)CO2)O)O)[C@H](C)O3)O)[C@]3([H])O[C@H]([C@H]([C@@H](O)CO4)O)[C@@H]4OC([C@]56[C@](CC(C)(C)CC6)([H])C7=CC[C@@]([C@@]8([C@@](C(CO)([C@@H](O[C@@]9([H])[C@@H]([C@H]([C@H](O)[C@@H](CO)O9)O[C@]%10([H])O[C@@H]([C@@H](O)[C@H](O)[C@H]%10O)CO)O)[C@@H](O)C8)CO)([H])CC%11)C)([H])[C@]%11(C)[C@]7(C)C[C@H]5O)=O
-
Structure Classification
-
Initial Source
-
선적
Room temperature in continental US; may vary elsewhere.
-
보관
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Publications (3)
-
Journal Impact Factor
-
Most Recent
-
Phytother Res
Platycodin D2 Mediates Incomplete Autophagy and Ferroptosis in Breast Cancer Cells by Regulating Mitochondrial ROS. [Abstract]2025 Feb;39(2):581-592. PMID: 39581858 -
Cancer Cell Int
Platycodin D2 enhances P21/CyclinA2-mediated senescence of HCC cells by regulating NIX-induced mitophagy. [Abstract]2024 Feb 19;24(1):79. PMID: 38374035 -
Molecules
Characterization of Saponins from Various Parts of Platycodon grandiflorum Using UPLC-QToF/MS. [Abstract]2021 Dec 24;27(1):107. PMID: 35011337
용액&용해도
In Vitro:
DMSO : 100 mg/mL (72.07 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
In Vivo:
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.5 mg/mL (1.80 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.5 mg/mL (1.80 mM); Clear solution
This protocol yields a clear solution of ≥ 2.5 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (25.0 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Protocol
-
RNA extraction experimental
By lysing cells, releasing RNA, and removing impurities such as proteins and DNA, high-purity RNA products are finally obtained. The commonly used traditional method is the guanidine isothiocyanate/phenol/chloroform method (Trizol), which is suitable for a variety of animal materials including animal tissues, microorganisms, cultured cells, etc., and most plant materials.
-
Somatic Cell Culture
A method of simulating the in vivo environment in vitro to maintain the cell growth, differentation and main functions.
-
Liver Cancer Modeling
Liver cancer can be classified into primary liver cancer and secondary liver cancer. Secondary liver cancer is the metastatic liver cancer. Primary liver cancer includes hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC) and fibrolamellar HCC, of which HCC is the most common form, accounting for approximately 90% of primary liver cancers[1]. HCC mouse models include chemical agent-induced models, transplanted tumor models, and genetic engineered models.
-
Breast Cancer Modeling
Breast cancer is a heterogeneous cancer, and it has been distinguished into four subtypes: luminal A, luminal B, HER2-positive and basal-like. Molecular mutations, epigenetic alterations, hormone exposure and immune microenvironment are related to the progression of breast cancer.
-
Senescence-associated β-galactosidase staining
Senescence-associated β-galactosidase staining detects β-galactosidase activity that is histochemically visible at pH 6. 0 in senescent cells, where X-gal cleavage produces an insoluble blue precipitate observable by bright-field microscopy. This activity reflects increased lysosomal β-galactosidase/lysosomal mass rather than a senescence-essential enzyme, because GLB1 depletion or genetic lysosomal β-galactosidase deficiency can abolish SA-β-gal staining while cells still undergo senescence. SA-β-gal was originally reported in senescent but not presenescent fibroblasts and keratinocytes, absent from quiescent fibroblasts and terminally differentiated keratinocytes, and increased with donor age in human skin samples. Because SA-β-gal can also appear in some non-senescent or tissue-specific contexts, interpretation should be paired with experimental controls and, when possible, independent senescence markers.
-
Mitochondrial membrane-potential and mitochondrial mass staining
Mitochondrial membrane potential staining measures the electrochemical polarization across the mitochondrial inner membrane in live cells using lipophilic cationic fluorescent probes; early rhodamine-based work showed that selective mitochondrial dye accumulation is lost when the mitochondrial transmembrane potential is dissipated. JC-1 reports mitochondrial polarization by shifting from green monomer fluorescence to red J-aggregate fluorescence as dye concentration increases within energized mitochondria; therefore, the red/green fluorescence ratio is used as a relative readout of mitochondrial membrane potential. TMRE or TMRM staining provides a single-channel relative readout because these cationic rhodamine esters accumulate in polarized mitochondria, and lower fluorescence indicates reduced mitochondrial polarization when acquisition and dye-loading conditions are controlled. Mitochondrial mass staining is commonly performed with MitoTracker Green FM or related MitoTracker dyes as
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Ferroptosis Solutions
Ferroptosis is an iron-dependent, non-apoptotic form of regulated cell death characterized by lethal lipid peroxidation and sensitivity to suppression by iron chelators or lipophilic radical-trapping antioxidants. The core pathway links cystine uptake through system Xc−, glutathione availability, GPX4-dependent detoxification of phospholipid hydroperoxides, iron-dependent oxidative reactions, and polyunsaturated-phospholipid metabolism into a cell-death program that is biochemically and morphologically distinct from apoptosis, necrosis, and autophagy. The ferroptosis pathway is experimentally linked to phenotype through chemical and genetic perturbation. Erastin induces ferroptosis by inhibiting cystine uptake through system Xc− and weakening antioxidant defenses, while GPX4 inhibition or depletion causes lipid peroxide accumulation and ferroptotic cancer-cell death. ACSL4 and oxidizable arachidonoyl- or adrenoyl-containing phosphatidylethanolamines shape ferroptosis sensitivity by con
-
Mitophagy Solutions
Mitophagy is the selective autophagic degradation of mitochondria and functions as a mitochondrial quality-control pathway that removes damaged, depolarized, excess, or developmentally programmed mitochondria. The pathway links mitochondrial damage recognition, autophagosome recruitment, lysosomal delivery, and mitochondrial turnover to phenotypes such as mitochondrial homeostasis, oxidative-stress control, metabolic remodeling, differentiation, and neurodegeneration-related mitochondrial fidelity. The best-characterized damage-induced pathway is the PINK1-Parkin axis. Parkin is recruited selectively to impaired mitochondria and promotes their autophagic elimination, while mitochondrial depolarization stabilizes PINK1 on damaged mitochondria, recruits Parkin, and activates Parkin-dependent mitophagy. PINK1 also phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity, and PINK1-driven ubiquitin phosphorylation creates a feed-forward signal for recruiting autophagy machi
-
MTT Cell Proliferation Assay
The MTT assay is a colorimetric endpoint assay for estimating viable cell number, cell growth, cytotoxicity, or cell activation in cultured mammalian cells. Living cells reduce the yellow tetrazolium salt MTT into purple/blue formazan, while dead cells do not generate the same signal; the resulting color can be quantified with a multiwell spectrophotometer. MTT reduction is commonly interpreted as a readout of metabolic activity that often correlates with viable cell number, but it should not be treated as a direct cell-counting method unless the assay is optimized for the cell type and experimental condition. Studies show that MTT reduction can involve mitochondrial and non-mitochondrial reducing systems, and formazan may accumulate in intracellular lipid droplets rather than simply marking mitochondria.
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
-
RT-PCR
Reverse transcription technology uses RNA as a template to synthesize DNA. RT-PCR is simple, specific and sensitive, and can be used to detect gene expression levels and expression differences in cells; detect RNA virus content; clone cDNA sequences of specific genes.
-
Naïve CD4+ T-cell subset differentiation/polarization
Naïve CD4+ T-cell subset differentiation/polarization is an in vitro assay in which purified naïve CD4+ T cells are activated through TCR and CD28 costimulation and cultured with defined cytokines and neutralizing antibodies to generate Th0, Th1, Th2, Th17, or induced Treg-like populations. Differentiation is detected by subset-associated cytokines and transcription factors: IFN-γ/T-bet for Th1, IL-4/GATA3 for Th2, IL-17A/RORγt for Th17, and Foxp3 for induced Treg cells. The assay readout is usually generated by intracellular cytokine staining after restimulation, transcription-factor staining by flow cytometry, ELISA of secreted cytokines, or gene-expression analysis. The result reflects cytokine-directed lineage commitment or polarization rather than antigen-specific immune protection by itself.
-
BrdU Incorporation Assay
Bromodeoxyuridine (BrdU) incorporation assay is based on the principle that BrdU, a thymidine analog, is incorporated into newly synthesized DNA during the S phase of the cell cycle, thereby serving as a marker of DNA replication and cellular proliferation. Incorporated BrdU can be detected using anti-BrdU antibodies following DNA denaturation, enabling visualization or quantification of proliferating cells through immunochemical detection methods such as immunofluorescence or immunohistochemistry.
-
ROS/oxidative-stress fluorescent staining
ROS/oxidative-stress fluorescent staining uses cell-permeant fluorogenic probes that become fluorescent after oxidation inside cells or tissues; commonly used examples include DCFH-DA/DCFDA for broad cellular oxidant detection, DHE for superoxide-related signal detection, MitoSOX for mitochondrial superoxide-related signal detection, and CellROX probes for oxidative-stress-associated fluorescence readouts. The assay detects probe oxidation rather than a single ROS species unless the probe and analysis method have been chemically validated for that species. DCFH-DA enters cells, is deacetylated by intracellular esterases to DCFH, and produces fluorescent DCF after oxidation, so the readout is used as an operational measure of total cellular oxidative stress rather than a species-specific ROS measurement. DHE and MitoSOX can report superoxide-related oxidation, but red fluorescence alone can include non-specific ethidium-like oxidation products; HPLC or optimized spectral approaches are
-
CFSE Dye Dilution Proliferation Assay
The CFSE (carboxyfluorescein diacetate succinimidyl ester) dye dilution proliferation assay is based on the covalent labeling of intracellular proteins by a cell-permeant fluorescent dye that becomes fluorescent upon intracellular ester cleavage and then is stably retained within cells. As labeled cells divide, the dye is partitioned equally between daughter cells, resulting in a stepwise halving of fluorescence intensity that can be quantified by flow cytometry to determine the number of cell divisions undergone by each cell population. This fluorescence dilution approach enables quantitative tracking of lymphocyte proliferation at the single-cell level over multiple rounds of division. CFSE-based proliferation analysis has been widely applied to measure antigen-driven lymphocyte expansion in vitro, where discrete fluorescence peaks correspond to successive cell divisions and allow reconstruction of proliferative history within heterogeneous populations.
-
Dye-dilution cell tracking and proliferation staining
Dye-dilution cell tracking assays quantify cell proliferation by covalently labeling intracellular proteins with a stable fluorescent dye that is equally partitioned between daughter cells during mitosis, resulting in stepwise halving of fluorescence intensity with each cell division as measured by flow cytometry histograms. Carboxyfluorescein diacetate succinimidyl ester (CFSE) is a prototypical dye that diffuses into cells, is enzymatically converted into a fluorescent compound, and then covalently binds intracellular amine groups, producing long-lived fluorescence suitable for tracking multiple rounds of division in vitro and in vivo. Successive generations of dividing cells form discrete peaks of decreasing fluorescence intensity, enabling estimation of proliferation history, precursor frequency, and division index within heterogeneous populations. Alternative dyes such as CellTrace Violet (CTV) and far-red membrane dyes (e. g. , PKH26) follow the same dilution principle but differ
-
CCK-8/WST-8 Cell Proliferation Assay
The CCK-8/WST-8 assay is based on the reduction of the water-soluble tetrazolium salt WST-8 to a water-soluble formazan product by cellular dehydrogenases in metabolically active cells, where the generated formazan amount is proportional to the number of living cells and is quantified by measuring absorbance in the visible range, providing a colorimetric readout for cell viability and proliferation assessment. This class of tetrazolium-based assays improves upon earlier MTT-based systems by producing a water-soluble formazan, eliminating the need for organic solubilization steps and enabling direct spectrophotometric measurement in culture medium.
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
-
Cell Counting-Based Growth Curve Assay
Cell counting-based growth curve assays quantify cell proliferation by directly measuring changes in viable cell number over time using manual or automated counting methods such as hemocytometer-based counting or instrument-assisted cell enumeration, enabling construction of growth curves that reflect population expansion dynamics in response to culture conditions. A widely used approach is trypan blue exclusion with hemocytometer counting, where membrane-compromised (non-viable) cells take up the dye, allowing discrimination between viable and non-viable cells while simultaneously enabling total cell number quantification. Repeated sampling across time points allows estimation of proliferation rate, growth phases, and comparative growth kinetics between experimental conditions.
-
Research Protocol for Inflammation-related Diseases
The NLRP3 inflammasome is a cytosolic innate immune signaling platform that integrates priming signals and danger-signal activation to promote caspase-1 activation, maturation of IL-1β and IL-18, and gasdermin D-mediated pyroptotic cell death. The core experimental logic is to determine whether inflammatory disease phenotypes are driven by increased NLRP3 expression, ASC-containing inflammasome assembly, caspase-1 cleavage, GSDMD cleavage, and extracellular release of IL-1β/IL-18 rather than by nonspecific cell injury alone. The pathway is strongly linked to inflammation-related disease phenotypes because monosodium urate crystals activate NALP3/NLRP3 inflammasome signaling in gout-like crystal inflammation, cholesterol crystals activate NLRP3 inflammasomes in atherogenesis models, and DSS-induced intestinal inflammation has been reported to involve NLRP3 inflammasome activity. However, experimental colitis studies also show context-dependent protective effects of NLRP3 inflammasome co
-
Colony Formation (Clonogenic) Assay
The clonogenic (colony formation) assay measures the ability of a single cell to retain reproductive viability and form a macroscopic colony, typically defined as a cluster derived from one progenitor cell after a defined growth period. This assay is widely used to evaluate cell survival after exposure to ionizing radiation or cytotoxic treatments and is considered a standard method in radiation biology for generating dose-response relationships of reproductive cell death. Colony formation reflects long-term proliferative capacity rather than short-term metabolic activity, and survival is quantified by comparing treated versus untreated conditions based on colony number and derived survival fractions.
-
Real Time qPCR (Q-PCR)
Real-time quantitative PCR (qPCR) quantifies an amplifiable nucleic-acid target by monitoring fluorescence during PCR cycling rather than measuring product only after amplification. The increase in fluorescence tracks accumulation of PCR product, and the quantification cycle (Cq; historically also Ct/CP) is related to the initial amount of target: samples containing more starting target generally reach the defined fluorescence threshold in fewer cycles.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
-
EdU Incorporation Assay (Click Chemistry-Based DNA Synthesis Measurement)
The EdU incorporation assay measures DNA synthesis by adding the thymidine analog 5-ethynyl-2′-deoxyuridine to cells or tissues, where it is incorporated into newly synthesized DNA during S phase. Incorporated EdU is detected by copper-catalyzed azide-alkyne cycloaddition, in which a fluorescent azide covalently reacts with the ethynyl group on EdU, allowing S-phase cells to be detected by fluorescence microscopy, flow cytometry, or high-content imaging. EdU detection does not require DNA denaturation or anti-BrdU antibody access, which preserves sample structure and improves compatibility with immunostaining and multiparameter cytometry compared with BrdU-based detection. EdU can be cytotoxic in a cell-type- and exposure-dependent manner, so pulse duration, concentration, and continuous-labeling designs should be validated for each cell type.
-
Ki-67 Immunostaining Proliferation Assay
Ki-67 immunostaining measures the growth fraction of a cell population by detecting Ki-67, a nuclear antigen present in proliferating cells and absent in quiescent G0 cells. The readout is the percentage of Ki-67-positive nuclei among total counted cells, commonly called the Ki-67 labeling index or proliferation index.
-
PCNA Immunodetection Proliferation Assay
PCNA immunodetection measures proliferative activity by detecting proliferating cell nuclear antigen, a nuclear protein associated with DNA polymerase δ function and DNA replication. The assay readout is the proportion of PCNA-positive nuclei among total counted cells, but PCNA labeling is not identical to BrdU labeling because PCNA can mark late G1/early S-associated replication competence and may persist beyond active DNA synthesis depending on fixation and extraction conditions.
-
Protocol for Cell Counting and Cell Density Analysis
Cell counting and cell-density analysis estimate the number of cells in a known volume or field area. Manual hemocytometer counting uses a chamber of defined geometry to convert counted cells into cells/mL, while automated counters and image-analysis workflows detect cell objects from optical, brightfield, fluorescence, impedance, or digital-image features. Trypan blue viability counting is based on dye exclusion: viable cells with intact membranes exclude dye, while non-viable cells with compromised membranes stain blue. The readout is total cell density, viable-cell density, dead-cell density, and percent viability. Cell density can also be estimated from microscopy images by counting objects per image area, from flow cytometry using calibrated volume or reference particles, or from in situ microscopy in bioreactors after calibration against reference methods such as hemocytometer or flow cytometry.
순도&문서
-
Data Sheet (292 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
References
[1]. Sun L, et al. Platycodin D2 enhances P21/CyclinA2-mediated senescence of HCC cells by regulating NIX-induced mitophagy. Cancer Cell Int. 2024;24(1):79. Published 2024 Feb 19. [Content Brief]
[2]. Xie Y, et al. Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses. Int Immunopharmacol. 2008;8(8):1143-1150. [Content Brief]
[3]. Li Y, et al. Platycodin D2 Mediates Incomplete Autophagy and Ferroptosis in Breast Cancer Cells by Regulating Mitochondrial ROS. Phytother Res. 2025;39(2):581-592. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 0.7207 mL | 3.6037 mL | 7.2074 mL | 18.0185 mL |
| 5 mM | 0.1441 mL | 0.7207 mL | 1.4415 mL | 3.6037 mL | |
| 10 mM | 0.0721 mL | 0.3604 mL | 0.7207 mL | 1.8019 mL | |
| 15 mM | 0.0480 mL | 0.2402 mL | 0.4805 mL | 1.2012 mL | |
| 20 mM | 0.0360 mL | 0.1802 mL | 0.3604 mL | 0.9009 mL | |
| 25 mM | 0.0288 mL | 0.1441 mL | 0.2883 mL | 0.7207 mL | |
| 30 mM | 0.0240 mL | 0.1201 mL | 0.2402 mL | 0.6006 mL | |
| 40 mM | 0.0180 mL | 0.0901 mL | 0.1802 mL | 0.4505 mL | |
| 50 mM | 0.0144 mL | 0.0721 mL | 0.1441 mL | 0.3604 mL | |
| 60 mM | 0.0120 mL | 0.0601 mL | 0.1201 mL | 0.3003 mL |